BEAM logo

Beam Therapeutics (BEAM) EBITDA

annual EBITDA:

-$383.98M-$237.02M(-161.29%)
December 31, 2024

Summary

  • As of today (June 23, 2025), BEAM annual EBITDA is -$383.98 million, with the most recent change of -$237.02 million (-161.29%) on December 31, 2024.
  • During the last 3 years, BEAM annual EBITDA has risen by +$1.04 million (+0.27%).
  • BEAM annual EBITDA is now -435.90% below its all-time high of -$71.65 million, reached on December 31, 2019.

Performance

BEAM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

quarterly EBITDA:

-$113.76M-$28.83M(-33.95%)
March 31, 2025

Summary

  • As of today (June 23, 2025), BEAM quarterly EBITDA is -$113.76 million, with the most recent change of -$28.83 million (-33.95%) on March 31, 2025.
  • Over the past year, BEAM quarterly EBITDA has dropped by -$15.06 million (-15.26%).
  • BEAM quarterly EBITDA is now -177.00% below its all-time high of $147.74 million, reached on December 31, 2023.

Performance

BEAM quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

TTM EBITDA:

-$399.03M-$15.06M(-3.92%)
March 31, 2025

Summary

  • As of today (June 23, 2025), BEAM TTM EBITDA is -$399.03 million, with the most recent change of -$15.06 million (-3.92%) on March 31, 2025.
  • Over the past year, BEAM TTM EBITDA has dropped by -$247.66 million (-163.61%).
  • BEAM TTM EBITDA is now -462.47% below its all-time high of -$70.94 million, reached on September 30, 2019.

Performance

BEAM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BEAM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-161.3%-15.3%-163.6%
3 y3 years+0.3%-56.0%-54.1%
5 y5 years-435.9%-317.4%-361.1%

BEAM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-161.3%+0.3%-177.0%at low-171.5%at low
5 y5-year-435.9%+0.3%-177.0%+42.8%-361.1%at low
alltimeall time-435.9%+0.3%-177.0%+42.8%-462.5%at low

BEAM EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$113.76M(+33.9%)
-$399.03M(+3.9%)
Dec 2024
-$383.98M(+161.3%)
-$84.93M(-15.9%)
-$383.98M(+153.8%)
Sep 2024
-
-$101.03M(+1.7%)
-$151.31M(-1.3%)
Jun 2024
-
-$99.32M(+0.6%)
-$153.36M(+1.3%)
Mar 2024
-
-$98.70M(-166.8%)
-$151.37M(+3.0%)
Dec 2023
-$146.95M(-53.5%)
$147.74M(-243.3%)
-$146.95M(-60.4%)
Sep 2023
-
-$103.08M(+5.9%)
-$371.30M(+4.3%)
Jun 2023
-
-$97.33M(+3.2%)
-$356.05M(+5.6%)
Mar 2023
-
-$94.28M(+23.1%)
-$337.27M(+6.8%)
Dec 2022
-$315.90M(-18.0%)
-$76.61M(-12.8%)
-$315.90M(+5.3%)
Sep 2022
-
-$87.83M(+11.8%)
-$300.14M(+7.1%)
Jun 2022
-
-$78.55M(+7.7%)
-$280.19M(+8.2%)
Mar 2022
-
-$72.91M(+19.8%)
-$258.95M(-32.7%)
DateAnnualQuarterlyTTM
Dec 2021
-$385.01M(+200.7%)
-$60.85M(-10.4%)
-$385.01M(+5.9%)
Sep 2021
-
-$67.88M(+18.5%)
-$363.69M(+9.6%)
Jun 2021
-
-$57.30M(-71.2%)
-$331.91M(+10.7%)
Mar 2021
-
-$198.97M(+403.4%)
-$299.75M(+134.1%)
Dec 2020
-$128.03M(+78.7%)
-$39.53M(+9.5%)
-$128.03M(+12.4%)
Sep 2020
-
-$36.10M(+43.6%)
-$113.87M(+20.0%)
Jun 2020
-
-$25.14M(-7.8%)
-$94.88M(+9.6%)
Mar 2020
-
-$27.25M(+7.4%)
-$86.53M(+20.8%)
Dec 2019
-$71.65M(-38.3%)
-$25.37M(+48.2%)
-$71.65M(+1.0%)
Sep 2019
-
-$17.12M(+1.9%)
-$70.94M(-43.6%)
Jun 2019
-
-$16.79M(+35.7%)
-$125.82M(+15.4%)
Mar 2019
-
-$12.37M(-49.8%)
-$109.02M(+12.8%)
Dec 2018
-$116.09M
-$24.66M(-65.7%)
-$96.65M(+34.3%)
Sep 2018
-
-$71.99M
-$71.99M

FAQ

  • What is Beam Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Beam Therapeutics?
  • What is Beam Therapeutics annual EBITDA year-on-year change?
  • What is Beam Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Beam Therapeutics?
  • What is Beam Therapeutics quarterly EBITDA year-on-year change?
  • What is Beam Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Beam Therapeutics?
  • What is Beam Therapeutics TTM EBITDA year-on-year change?

What is Beam Therapeutics annual EBITDA?

The current annual EBITDA of BEAM is -$383.98M

What is the all time high annual EBITDA for Beam Therapeutics?

Beam Therapeutics all-time high annual EBITDA is -$71.65M

What is Beam Therapeutics annual EBITDA year-on-year change?

Over the past year, BEAM annual EBITDA has changed by -$237.02M (-161.29%)

What is Beam Therapeutics quarterly EBITDA?

The current quarterly EBITDA of BEAM is -$113.76M

What is the all time high quarterly EBITDA for Beam Therapeutics?

Beam Therapeutics all-time high quarterly EBITDA is $147.74M

What is Beam Therapeutics quarterly EBITDA year-on-year change?

Over the past year, BEAM quarterly EBITDA has changed by -$15.06M (-15.26%)

What is Beam Therapeutics TTM EBITDA?

The current TTM EBITDA of BEAM is -$399.03M

What is the all time high TTM EBITDA for Beam Therapeutics?

Beam Therapeutics all-time high TTM EBITDA is -$70.94M

What is Beam Therapeutics TTM EBITDA year-on-year change?

Over the past year, BEAM TTM EBITDA has changed by -$247.66M (-163.61%)
On this page